Michael S. Poirier, Chairman and CEO at Qualigen Therapeutics, Inc. (QLGN), bought 30,000 shares at $0.57 ($17K) on 2022-06-22, disclosed to the SEC on 2022-06-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.